Prime Medicine (PRME) Tax Rate (2021 - 2024)
Prime Medicine posted quarterly Tax Rate of 0.24% for Q2 2024, up 31.0% year-on-year from 0.18% in Q3 2023, and up 182.27% on a QoQ basis from 0.29% in Q1 2024.
Prime Medicine (PRME) has 4 years of Tax Rate data on file, last reported at 0.24% in Q2 2024.
- For the quarter ending Q2 2024, Tax Rate rose 31.0% year-over-year to 0.24%; the trailing twelve-month figure through Mar 2025 stood at 0.07% (up 9.0% YoY), and the FY2023 full-year result was 0.14%, down 63.0% from the prior year.
- Tax Rate for Q2 2024 stood at 0.24%, up from 0.29% in the prior quarter.
- Across five years, Tax Rate topped out at 12.62% in Q3 2021 and bottomed at 2.22% in Q4 2021.
- The 4-year median for Tax Rate is 0.24% (2024), against an average of 1.31%.
- Peak annual rise in Tax Rate reached 269 bps in 2022, while the deepest fall reached 1335 bps in 2022.
- A 4-year view of Tax Rate shows it stood at 2.22% in 2021, then jumped by 121 bps to 0.47% in 2022, then slumped by 55 bps to 0.21% in 2023, then increased by 14 bps to 0.24% in 2024.
- The last three Tax Rate figures came in at 0.24% (Q2 2024), 0.29% (Q1 2024), and 0.21% (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 57.14 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.68 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -6.79 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.51 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7.07 |
| 10 | Prime Medicine | 601.24 Mn | 601.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 0.24 |
| Jun 30, 2024 | 0.24 |
| Mar 31, 2024 | -0.29 |
| Mar 31, 2024 | -0.29 |
| Sep 30, 2023 | 0.21 |
| Sep 30, 2023 | 0.21 |
| Jun 30, 2023 | -0.07 |
| Jun 30, 2023 | -0.07 |
| Mar 31, 2023 | 0.51 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.47 |
| Dec 31, 2022 | 0.47 |
| Sep 30, 2022 | -0.73 |
| Sep 30, 2022 | -0.73 |
| Jun 30, 2022 | 1.48 |
| Jun 30, 2022 | 1.48 |
| Mar 31, 2022 | 2.18 |
| Mar 31, 2022 | 2.18 |
| Dec 31, 2021 | -2.22 |
| Dec 31, 2021 | -2.22 |
| Sep 30, 2021 | 12.62 |
| Sep 30, 2021 | 12.62 |